Robert L. Wolf

1.4k total citations
57 papers, 982 citations indexed

About

Robert L. Wolf is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Robert L. Wolf has authored 57 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in Robert L. Wolf's work include Blood Pressure and Hypertension Studies (10 papers), Hormonal Regulation and Hypertension (9 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Robert L. Wolf is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Hormonal Regulation and Hypertension (9 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Robert L. Wolf collaborates with scholars based in United States, Germany and France. Robert L. Wolf's co-authors include Milton Mendlowitz, Stanley E. Gitlow, Nosrat E. Naftchi, Sherwin Wilk, Elizabeth Wilk, Julia P. Roboz, C. William Hanke, Peter Kornfeld, Hans Pópper and David A. Dreiling and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Robert L. Wolf

56 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Wolf United States 16 218 218 136 126 119 57 982
Epstein Fh United States 20 140 0.6× 180 0.8× 421 3.1× 97 0.8× 24 0.2× 61 1.4k
John W. Boylan United States 19 200 0.9× 71 0.3× 323 2.4× 135 1.1× 35 0.3× 27 1.2k
Satoru Chiba Japan 17 225 1.0× 151 0.7× 295 2.2× 86 0.7× 42 0.4× 101 965
Henry O. Heinemann United States 19 98 0.4× 85 0.4× 202 1.5× 97 0.8× 73 0.6× 26 1.0k
R Goldstein Israel 17 229 1.1× 138 0.6× 326 2.4× 168 1.3× 575 4.8× 48 1.9k
Laurence H. Kyle United States 18 30 0.1× 282 1.3× 124 0.9× 176 1.4× 66 0.6× 47 1.2k
Isabel Hernández Spain 15 184 0.8× 183 0.8× 126 0.9× 73 0.6× 54 0.5× 42 727
Richard L. Malvin United States 24 426 2.0× 281 1.3× 499 3.7× 154 1.2× 26 0.2× 104 1.7k
Phyllis M. Hartroft United States 15 209 1.0× 264 1.2× 268 2.0× 59 0.5× 21 0.2× 23 1.0k
David W. Ploth United States 23 584 2.7× 277 1.3× 366 2.7× 188 1.5× 44 0.4× 58 1.6k

Countries citing papers authored by Robert L. Wolf

Since Specialization
Citations

This map shows the geographic impact of Robert L. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Wolf more than expected).

Fields of papers citing papers by Robert L. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Wolf. The network helps show where Robert L. Wolf may publish in the future.

Co-authorship network of co-authors of Robert L. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Wolf. A scholar is included among the top collaborators of Robert L. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Wolf. Robert L. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, K., et al.. (2009). Investigations on the influence of bradykinin upon the motility of ram spermatozoa. Andrologia. 23(5). 357–362. 2 indexed citations
2.
Engelbrecht, Bettina M. J., James W. Dalling, T. Pearson, et al.. (2006). Short dry spells in the wet season increase mortality of tropical pioneer seedlings. Oecologia. 148(2). 258–269. 108 indexed citations
3.
Ophir, J., Robert L. Wolf, A. Tamir, & Marina Landau. (1992). Squamous Cell Carcinoma – 70 Years after Irradiation. Dermatology. 184(3). 213–215. 3 indexed citations
4.
Hanke, C. William, et al.. (1983). Chemosurgical Reports: Perineural Spread of Basal‐Cell Carcinoma. The Journal of Dermatologic Surgery and Oncology. 9(9). 742–747. 64 indexed citations
5.
Berberich, R., M. Besnard, Yehudi A. Cohen, et al.. (1980). Nuklearmedizin / Nuclear Medicine. 2 indexed citations
6.
Mendlowitz, Milton, et al.. (1971). Identification of Essential Hypertension in Patients with Labile Blood Pressures. CHEST Journal. 59(4). 402–406. 18 indexed citations
7.
Mendlowitz, Milton, Robert L. Wolf, & Stanley E. Gitlow. (1970). Catecholamine metabolism in essential hypertension. American Heart Journal. 79(3). 401–407. 12 indexed citations
8.
Kornfeld, Peter, Arthur J. Samuels, Robert L. Wolf, & Kermit E. Osserman. (1970). Metabolism of 14 C‐labeled pyridostigmine in myasthenia gravis. Neurology. 20(7). 634–634. 26 indexed citations
9.
Gitlow, Stanley E., Milton Mendlowitz, Elizabeth Wilk, et al.. (1968). Excretion of catecholamine catabolites by normal children.. PubMed. 72(4). 612–20. 59 indexed citations
10.
Mendlowitz, Milton, et al.. (1967). The Effect of Tyramine on the Digital Circulation in Normotensive and Hypertensive Subjects. Diseases of the Chest. 52(6). 709–714. 6 indexed citations
11.
Wolf, Robert L., Milton Mendlowitz, Julia P. Roboz, & Stanley E. Gitlow. (1966). Treatment of hypertension with antihypertensive diuretic drugs. American Heart Journal. 72(5). 692–697. 3 indexed citations
12.
Mendlowitz, Milton, Stanley E. Gitlow, Robert L. Wolf, & J. Tuckman. (1965). The metabolism of hypertension. American Heart Journal. 70(5). 677–690. 8 indexed citations
13.
Mendlowitz, Milton, Nosrat E. Naftchi, Robert L. Wolf, & Stanley E. Gitlow. (1965). The effects of guanethidine and of alpha-methyldopa on the digital circulation in hypertension. American Heart Journal. 69(6). 731–739. 10 indexed citations
14.
Gitlow, Stanley E., Milton Mendlowitz, Elizabeth Wilk, et al.. (1964). Plasma Clearance of dl-β-H3-Norepinephrine in Normal Human Subjects and Patients with Essential Hypertension*. Journal of Clinical Investigation. 43(10). 2009–2015. 48 indexed citations
15.
Wolf, Robert L., Milton Mendlowitz, Nosrat E. Naftchi, & Stanley E. Gitlow. (1963). Current treatment of hypertension with drugs. American Heart Journal. 66(3). 414–428. 7 indexed citations
16.
Wolf, Robert L., et al.. (1962). Metabolism and distribution of I-131-labeled angiotensin II.. PubMed. 60. 150–9. 7 indexed citations
17.
Mendlowitz, Milton, Robert L. Wolf, Stanley E. Gitlow, & Nosrat E. Naftchi. (1962). Angiotensin II Studies in Hypertension. Circulation. 25(1). 231–236. 11 indexed citations
18.
Wolf, Robert L., et al.. (1962). Results of Pharmacologic Treatment in the Malignant Carcinoid Syndrome. New England Journal of Medicine. 267(9). 435–438. 23 indexed citations
19.
Wolf, Robert L., Milton Mendlowitz, Stanley E. Gitlow, & Nosrat E. Naftchi. (1961). Metabolism of Angiotensin II-I 131 in Normotensive and Hypertensive Human Subjects. Circulation. 23(5). 754–758. 14 indexed citations
20.
Wolf, Robert L., et al.. (1960). Chronic idiopathic jaundice. The American Journal of Medicine. 28(1). 32–41. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026